Market Data
Market Cap₹1,060.22 Cr.
52W High₹344.6
Current Price₹192.9
52W Low₹155.65
Down from 52W High44 %
Face Value₹2
Performance
ROCE12.71 %
ROE12.7 %
EPS (TTM)₹1.87
EPS Prev Qtr₹1.83
EPS Last Year₹1.59
EBITDA Qtr₹10.04 Cr.
Book Value₹44
Financial Health
Debt/Equity0.05
Debt/Profit0.45
Total Assets₹293.97 Cr.
Promoter Holding41.8 %
Earning Power9.94 %
Valuation
Stock P/E34.08
Industry P/E40.99
Price to Book4.36
Price to Sales3.69
Graham Number₹75.06
Key Metrics
Face Value
₹2
About Laxmi Dental Ltd
Healthcare · Healthcare
Laxmi Dental Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹2. Market cap ₹1,060.22 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a manageable debt-to-equity ratio of 0.05, indicating low financial risk.
- The Return on Capital Employed (ROCE) is 14.82%, showing efficient use of capital.
- The Return on Equity (ROE) is 13.75%, reflecting good profitability relative to shareholder equity.
- The company has a solid promoter holding of 41.8%, suggesting strong control and alignment of interests.
Weaknesses
- The P/E ratio of 34.39 indicates that the stock may be overvalued relative to its earnings.
- The P/B ratio of 5.13 suggests that the market values the company at a premium compared to its book value.
- The dividend yield is not available, indicating that the company may not currently pay dividends.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 72.27 | 66.04 | 73.95 | 74.7 |
| ↳ QoQ Growth | - | -8.6% | +12.0% | +1.0% |
| Expenses | 64.99 | 63.25 | 64.83 | 64.66 |
| Operating Profit | 7.27 | 2.8 | 9.12 | 10.04 |
| OPM % | 10.06% | 4.24% | 12.33% | 13.44% |
| Other Income | 2.39 | 2.08 | 2.36 | 2.3 |
| Interest | 0.24 | 0.32 | 0.35 | 0.3 |
| Depreciation | 3.75 | 4.17 | 4.38 | 4.32 |
| EBITDA | 11.02 | 6.97 | 13.5 | 14.36 |
| EBITDA Margin % | 15.25% | 10.55% | 18.26% | 19.22% |
| Profit Before Tax | 9.42 | -1.23 | 11.14 | 12.04 |
| Tax % | 19.85% | 175.61% | 4.49% | 20.68% |
| Net Profit | 7.56 | 0.93 | 10.64 | 9.55 |
| ↳ QoQ Growth | - | -87.7% | +1044.1% | -10.2% |
| EPS | 1.59 | 0.37 | 1.83 | 1.87 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 10.992 | 10.99 |
| Reserves | 197.545 | 232.33 |
| Borrowings | 11.37 | 13.01 |
| Other Liabilities | 64.76 | 37.64 |
| Total Liabilities | 284.665 | 293.97 |
| Fixed Assets | 50.749 | 59.24 |
| CWIP | 0 | 0 |
| Investments | 10.38 | 27.27 |
| Other Assets | 223.54 | 207.46 |
| Total Assets | 284.665 | 293.97 |
Cash Flows
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity | 43.832 | -4.997 |
| Cash from Investing Activity | -29.242 | -79.584 |
| Cash from Financing Activity | 110.642 | -17.752 |
| Net Cash Flow | 125.232 | -102.333 |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 41.7% | 41.7% | 41.77% | 41.8% |
| FIIs % | 32.39% | 32.45% | 31.21% | 30.1% |
| DIIs % | 11.85% | 10.82% | 10.52% | 10.89% |
| Public % | 9.26% | 10.18% | 11.52% | 11.82% |
| No. of Shareholders | 37,909 | 38,635 | 38,161 | 36,937 |
Major Shareholders (>1%)
- Orbimed Asia Ii Mauritius LimitedPublic Shareholding22.41%
- Rajesh Vrajlal KhakharPromoter and Promoter Group16.95%
- Sameer Kamlesh MerchantPromoter and Promoter Group15.83%
- Jigna Rajesh KhakharPromoter and Promoter Group7.84%
As of 2026-06-30View all shareholders →